Regenxbio (RGNX) Operating Income (2014 - 2026)
Regenxbio's Operating Income came in at $29.26 million for Q2 2026, compared with -$63.28 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Operating Income (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regenxbio reported Operating Income of -$164.15 million; for FY2025, it was -$161.2 million.
- Going back by year, Operating Income was -$233.35 million in FY2024, -$268.13 million in FY2023, -$262.88 million in FY2022 and $159.98 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Operating Income since Q4 2021.
- Business Quant data shows RGNX's Operating Income at -$83.36 million (Q1 2026), -$57.64 million (Q4 2025) and -$52.41 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | -35.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -35.53 Mn |
| Jun 30, 2026 | 29.26 Mn |
| Mar 31, 2026 | -83.36 Mn |
| Dec 31, 2025 | -57.64 Mn |
| Sep 30, 2025 | -52.41 Mn |
| Jun 30, 2025 | -63.28 Mn |
| Mar 31, 2025 | 12.13 Mn |
| Dec 31, 2024 | -51.37 Mn |
| Sep 30, 2024 | -62.08 Mn |
| Jun 30, 2024 | -56.04 Mn |
| Mar 31, 2024 | -63.86 Mn |
| Dec 31, 2023 | -63.90 Mn |
| Sep 30, 2023 | -64.96 Mn |
| Jun 30, 2023 | -73.11 Mn |
| Mar 31, 2023 | -66.16 Mn |
| Dec 31, 2022 | -57.77 Mn |
| Sep 30, 2022 | -71.05 Mn |
| Jun 30, 2022 | -62.53 Mn |
| Mar 31, 2022 | -71.53 Mn |
| Dec 31, 2021 | 313.60 Mn |
API Access
Regenxbio Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();